Sentinel Lymph Node Biopsy in Patients with Clinically Negative Lymph Node After Neoadjuvant Chemotherapy
Journal of Breast Cancer. 2007;10(4):254 
Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients
Radiation Oncology Journal. 2014;32(3):132
Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
Breast Cancer Research. 2005;7(S1):
Is sentinel lymph node biopsy necessary for all clinically node negative breast cancer patients?
Journal of Surgical Research. 2004;121(2):301
2–31 Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy
Breast Diseases: A Year Book Quarterly. 2007;18(2):172
Axillary recurrences after sentinel lymph node biopsy: A multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients
Breast Diseases: A Year Book Quarterly. 2013;24(2):172-173
Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients
The Breast. 2004;13(4):290-296
P69 Sentinel lymph node biopsy is feasible for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy
The Breast. 2007;16:S32
Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodes
Breast Cancer. 1999;6(3):259-262
Predictive Factors for Non–Sentinel Lymph Node Metastasis in Patients With Clinically Node-Negative Ipsilateral Multiple Breast Cancer Treated With Total Mastectomy
Clinical Breast Cancer. 2015;15(5):362-369